These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 26566409)

  • 1. Japanese Physicians' Views on Drug Post-Marketing Surveillance.
    Maeda K; Katashima R; Ishizawa K; Yanagawa H
    J Clin Med Res; 2015 Dec; 7(12):956-60. PubMed ID: 26566409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Nationwide Survey on Informed Consent and Ethical Review at Hospitals Conducting Post-marketing Studies Sponsored by Pharmaceutical Companies].
    Urushihara H; Murakami Y; Matsui K; Tashiro S
    Yakugaku Zasshi; 2018 Jan; 138(1):63-71. PubMed ID: 28943593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical trials for drug approval: a pilot study of the view of doctors at Tokushima University Hospital.
    Yanagawa H; Nishiya M; Miyamoto T; Shikishima M; Imura M; Nakanishi R; Ariuchi K; Akaishi A; Takai S; Abe S; Kisyuku M; Kageyama C; Sato C; Yamagami M; Urakawa N; Sone S; Irahara M
    J Med Invest; 2006 Aug; 53(3-4):292-6. PubMed ID: 16953067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Change of Reference to Post-Marketing Surveillance Based on the Sequence of Revising the Pharmaceutical Affairs Law.
    Takahashi H
    Yakushigaku Zasshi; 2016; 51(1):29-39. PubMed ID: 30183145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. View of physicians on and barriers to patient enrollment in a multicenter clinical trial: experience in a Japanese rural area.
    Yanagawa H; Kishuku M; Akaike M; Azuma H; Irahara M
    Int Arch Med; 2010 Jun; 3():7. PubMed ID: 20525325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmaceutical marketing strategies' influence on physicians' prescribing pattern in Lebanon: ethics, gifts, and samples.
    Khazzaka M
    BMC Health Serv Res; 2019 Jan; 19(1):80. PubMed ID: 30700295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethical decision making and patient autonomy: a comparison of physicians and patients in Japan and the United States.
    Ruhnke GW; Wilson SR; Akamatsu T; Kinoue T; Takashima Y; Goldstein MK; Koenig BA; Hornberger JC; Raffin TA
    Chest; 2000 Oct; 118(4):1172-82. PubMed ID: 11035693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The views of doctors on registration trials in a Japanese rural area: a survey of medical institutions registered to the Tokushima Network for Clinical Trials.
    Yanagawa H; Irahara M; Kawashima S; Kagawa S;
    J Int Med Res; 2008; 36(5):1117-22. PubMed ID: 18831909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global marketing of cholesterol-lowering drugs as therapy.
    Elimimian JU; Gilmore JM; Singletary TJ
    J Hosp Mark Public Relations; 2006; 16(1-2):15-28. PubMed ID: 17194684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Worldwide, 3-Year, Post-Marketing Surveillance Experience with Tofacitinib in Rheumatoid Arthritis.
    Cohen S; Curtis JR; DeMasi R; Chen Y; Fan H; Soonasra A; Fleischmann R
    Rheumatol Ther; 2018 Jun; 5(1):283-291. PubMed ID: 29470834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are gifts from pharmaceutical companies ethically problematic? A survey of physicians.
    Brett AS; Burr W; Moloo J
    Arch Intern Med; 2003 Oct; 163(18):2213-8. PubMed ID: 14557219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An international survey of physicians regarding clinical trials: a comparison between Kyoto University Hospital and Seoul National University Hospital.
    Ito-Ihara T; Hong JH; Kim OJ; Sumi E; Kim SY; Tanaka S; Narita K; Hatta T; Choi EK; Choi KJ; Miyagawa T; Minami M; Murayama T; Yokode M
    BMC Med Res Methodol; 2013 Oct; 13():130. PubMed ID: 24156760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Marketing Approval of Ethical Kampo Medicines].
    Hakamatsuka T
    Yakugaku Zasshi; 2017; 137(2):163-165. PubMed ID: 28154326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Family Issues in Japanese Clinics: Concordance between Patients' and Physicians' Views.
    Takenaka H; Ban N; Kido T; Takeda S; Sato J
    JMA J; 2021 Jul; 4(3):254-261. PubMed ID: 34414320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possibility of Database Research as a Means of Pharmacovigilance in Japan Based on a Comparison with Sertraline Postmarketing Surveillance.
    Hirano Y; Asami Y; Kuribayashi K; Kitazaki S; Yamamoto Y; Fujimoto Y
    Value Health Reg Issues; 2018 May; 15():1-5. PubMed ID: 29474173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postmarketing Surveillance Studies-An Industry Perspective on Changing Global Requirements and Implications.
    Haque A; Daniel S; Maxwell T; Boerstoel M
    Clin Ther; 2017 Apr; 39(4):675-685. PubMed ID: 28392076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of a Healthcare Claims Database for Post-Marketing Safety Assessments of Eribulin in Japan: A Comparative Assessment with a Prospective Post-Marketing Surveillance Study.
    Sakata Y; Matsuoka T; Ohashi S; Koga T; Toyoda T; Ishii M
    Drugs Real World Outcomes; 2019 Mar; 6(1):27-35. PubMed ID: 30847841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The origin of informed consent].
    Mallardi V
    Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fatal adverse drug reactions of anticancer drugs detected by all-case post-marketing surveillance in Japan.
    Mori J; Tanimoto T; Miura Y; Kami M
    Jpn J Clin Oncol; 2015 Jun; 45(6):588-94. PubMed ID: 25759486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.